5. CONFLICT OF INTEREST
All members of the Neuro-urology Guidelines Working Group have provided disclosure statements of all relationships that they have that might be perceived as a potential source of a conflict of interest. This information is provided below and is also publicly available on the EAU website: https://uroweb.org/guidelines/neuro-urology/panel.
This Guidelines document was developed with the financial support of the European Association of Urology. No external sources of funding and support have been involved. The EAU is a non-profit organisation, and funding is limited to administrative and travel and meeting expenses. No honoraria or other reimbursements have been provided.
Disclosures: The EAU Guidelines Office certifies that all conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject matter or materials discussed in the manuscript (e.g. employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), are the following: R. Hamid reported serving as a company consultant to Contura and receiving company speaker honoraria or consultation fees from Allergan, Laborie and Boston Scientific. C. Hentzen reported serving as a company consultant to Covatec, Hollister and Boston Scientific; receiving honoraria or consultation fees from BBRAUN; and receiving fellowship or travel grants from Abbvie and Ipsen. G. Karsenty reported receiving honoraria or consultation fees from Boston Scientific and acting as a company consultant for Boston Scientific. S. Musco reported serving as a company consultant to ConvaTec Limited and receiving company speaker honorarium from ConvaTec Italia and Limited, Edi.ermes, B. Braun Milano Spa, Teleflex Medical S.R.L., Pierre Fabre, Hollister Italia, and Ecupharma S.r.l. B.Y. Padilla Fernandez reported receiving company speaker honorarium from Inmunotek and Medtronic Iberia S.A and trial participation with Idorsia. J.N. Panicker reported receiving honoraria or consultation fees from Astellas; company speaker honorarium from Astellas; research support from FirstKind Limited; owner of a patent in Cambridge University Press; and was a company consultant for Indorsia, Coloplast and Medice. B. Blok, T.M. Kessler, P. de Keijzer, A. van der Vorm, H. Ecclestone, D. Frings, M.L. Gallo, O. Gross and A.M. Sartori have nothing to declare.